Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsAntibody production from hybridoma has been found widespread use in various fields. Monoclonal antibodies prepared from murine hybridoma offer several advantages, including a stable source, easy preparation, and high yield. As a result, they are commonly used for immunodetection analysis and early disease screening. Preparing murine hybridoma monoclonal antibodies involves several steps, such as antigen design and screening, animal immunization, cell fusion screening technology, antibody purification, among others.
The general procedure for mouse hybridoma preparation involves antigen preparation and identification, animal immunization with the antigen, and determining the serum titer of the immunized animals. Once the titer has reached the required level, the spleen cells and myeloma cells are fused. Hybridoma cells are then screened using HAT and HT selective media and indirect ELISA to determine if the resulting hybridomas can both proliferate indefinitely and secrete hybridoma antibodies specific to the antigen.
In transgenic technology, the antibody gene encoding humanized antibody is transferred into the antibody gene null mice. Depending on the transferred genes, the hybridomas prepared from transgenic mice can be divided into chimeric antibodies and fully humanized antibodies. A chimeric antibody is an antibody molecule composed of the variable region gene of a murine antibody and the constant region gene of a human antibody through DNA recombination, assembled with a vector and transfected into cells for expression. The transgenic technology reduces the mouse-derived components, thus reducing the rejection caused by mouse-derived antibodies and helping to improve efficacy. Fully humanized antibody refers to the transfer of all human antibody coding genes into genetically modified antibody gene-deficient mice through genetic recombination technology, allowing the mouse expression system to fully express human antibodies.
Creative Biolabs would like to share our experience in the field of murine hybridoma with you. We sincerely hope your research goes well.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
